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INTRODUCTION
Pseudorabies (PR) is an infection of swine manifested by various degrees of respiratory distress, nervous disorders and mortality (Baskerville et al., 1973) . The causative agent of PR is a virus classified as a member of the alphaherpesvirinae (suid herpesvirus 1).
Although pigs are considered to be the natural host of PR virus (PRV) a variety of domestic and wild animals may also be infected. In pigs the severity of the clinical signs and mortality depend mainly on the age of the host and the virulence of the virus strain involved. In most nonporcine animals the disease is usually fatal.
PR is distributed worldwide and causes considerable economic losses in pig husbandry. Although losses can be limited by vaccination, eradication of PR is difficult since latency of virulent PRV in pigs is not prevented by passive or active immunization (Van Oirschot & Gielkens, 1984a, b) .
Differences in biological properties have been observed between field isolates of PRV (Baskerville et al., 1973) . In the past, attempts have been made to find biological markers, such as plaque morphology, heat-or trypsin-sensitivity, to distinguish PRV strains with different virulence properties (Skoda et al., 1964; Bartha et al., 1969) . Although some of these in vitro methods allowed differentiation between virulent strains and some vaccine strains, they have not found general acceptance.
An alternative approach to differentiate herpesvirus isolates has been to compare their viral DNA by restriction endonuclease analysis. This technique was successfully applied in the identification of different isolates of each serotype of herpes simplex virus (Hayward et al., 1975) and proved to be a powerful tool for epidemiological studies (Buchman et al., 1978; Lonsdale et al., 1979) . Similarly, restriction endonuclease cleavage has been used to differentiate isolates of cytomegalovirus (Kilpatrick et al., 1976) , Epstein-Barr virus (Rymo et al., 1979) , varicellazoster virus (Straus et al., 1983) , bovine herpesvirus type 1 (Engels et al., 1981) and equine herpesvirus type 1 (Allen et al., 1983) . Analysis of DNA isolated from different strains of PRV, either clinical isolates or commercial vaccines, revealed that the electrophoretic patterns of epidemiologically unrelated isolates vary with respect to number and size of the restriction endonuclease fragments (Gielkens & Berns, 1982; Ludwig et al., 1982; Geck et al., 1982a, b) .
The genome of PRV has been shown to be a linear double-stranded DNA molecule of approximately 90 x 106 daltons (Rubenstein & Kaplan, 1975) . The DNA consists of a short unique sequence (Us), bracketed by inverted terminal and internal repeat sequences (TRs and IRs, respectively) and a long unique sequence (UL) . The short unique region can invert in orientation with respect to the long unique region, generating two isomeric forms.
In this study, we have compared the genomes of different field isolates and modified live virus vaccine strains of PRV by BamHI restriction endonuclease analysis. Compared to wild-type strains, significant alterations were observed in the DNA of the vaccine strains. Furthermore, the data obtained indicated the existence of genetic heterogeneity among field isolates. Two types of variations were observed: (i) additions and/or deletions of nucleotide sequences to fragments derived from the TRs and IRs regions of the genome and (ii) loss or gain of BamHI cleavage sites within the UL region of the genome.
METHODS
Viruses and cell cultures. The 50 Dutch PRV strains examined were generally field isolates from different PR outbreaks. Some isolates were from diseased pigs vaccinated shortly before PR problems arose. The French set of PRV strains, generously provided by Dr B. Toma (Ecole Nationale V6t6rinaire d'Alfort, Maisons-Alfort) consisted of 33 isolates from several Departments of the country and various animal species such as pig, cattle, sheep, dog and cat. The Danish PRV strains, kindly provided by Dr V. Bitsch (State Veterinary Serum Laboratory, Copenhagen) had been isolated from cattle (isolates D-1 and D-2) and pigs (isolates D-3 and D-4). Isolates D-2 and D-3 were syncytium-forming strains. Four Hungarian strains of PRV were kindly provided by Dr B. Lomniczi (Veterinary Medical Research Institute, Budapest) . The highly virulent Northern Ireland three strain (NIA-3) of PRV, which was used as prototype strain in this study, and strains NIA-1 and NIA-2, were kindly supplied by Dr J. B. McFerran (Veterinary Research Laboratories, Belfast). The following PRV vaccines were studied. (i) Aescovac ~, based on strain Ercegovac. (ii) MK-25 ~' produced by Pharmachim, Sofia, Bulgaria. This strain has been passaged in chick embryo fibroblasts in the presence of iododeoxyuridine (Tatarov, 1968) . (iii) Duvaxyn ~, based on Bartha strain K-61 (Bartha, 1961) and produced by Duphar, Weesp, The Netherlands. (iv) Ay-vak ~, produced by Pliva, Zagreb, Yugoslavia. This vaccine contains the modified live B-KAL 68 strain. (v) Delsuvac *, based on the BUK TK/650-A strain (Skoda et al., 1964) and produced by Gist-Brocades, Delft, The Netherlands. PRV strains were grown on monolayers of secondary pig kidney cells (PK2) as previously described (Gielkens & Berns, 1982) , unless stated otherwise.
Isolation of NIA-3 virus DNA. NIA-3 virus was purified from the medium of infected baby hamster kidney cell suspension cultures by precipitation with polyethylene glycol and discontinuous sucrose gradient centrifugation. The virus pellet was suspended in 50 mM-Tris-HC1 pH 7-8, 10 mM-EDTA and lysed by the addition of SDS to a final concentration of 0.5~. Then 100 ~tg/ml of proteinase K (Boehringer) was added and the mixture was incubated for 2 h at 37 °C. The extracted virus DNA was purified by two cycles of sodium iodide density gradient centrifugation as described by Walboomers & Ter Schegget (1976) .
Extraction of DNAfrom infected cells. For the isolation of DNA from infected cells, cells were harvested when 70 to 90~ of the monolayer showed a cytopathic effect. Monolayers were washed with a solution containing 10 mM-Tris-HCl pH 7.4 and 150 mM-NaCI. Cells were harvested by scraping off, collected by low-speed centrifugation and resuspended in 50 mM-Tris-HC1 pH 7.8, 150 mM-NaC1, 10 mM-EDTA. Proteinase K and SDS were added to final concentrations of 100 ixg/ml and 0.5 ~ respectively. The lysates were incubated at 37 °C for 2 h and then extracted twice with a mixture of phenol :metacresol : 8-hydroxyquinoline (100:14:0-1) saturated with 50 mMTris-HCl pH 7.8, and twice with chloroform :isoamyl alcohol (24:1). The nucleic acids were precipitated with ethanol and dissolved in 10 mM-Tris-HCl pH 7.8, 1 mM-EDTA. DNA preparations were then incubated with 20 ~tg/ml of pancreatic ribonuclease (Boehringer) for 1 h at room temperature, followed by incubation with 100 p,g/ml of proteinase K for 1 h at 37 °C. The solution was extracted twice with chloroform: isoamyl alcohol and the DNA precipitated with ethanol. The precipitate was dissolved in 10 mM-Tris HCI pH 7-4, 1 mM-EDTA.
RestrietionendonueleasedigestionofDNA, electrophoresisandelution. Restriction endonucleases were purchased from Bethesda Research Laboratories. All digestions were performed at 37 °C for 2 h in the buffer system recommended by the manufacturer. The reactions were stoppedby the addition of 0.2 vol. 50 mM-EDTA (pH 7.4), 2.5% SDS, 50% glycerol, 0.125% bromophenol blue and heating the samples to 65 °C for 10 m in.
DNA restriction endonuclease fragments were subjected to electrophoresis at 1 V/cm for 40 h on horizontal 0.6% agarose gels in 40 mM-Tris-acetate pH 7.9, 5 mM-sodium acetate, 1 mM-EDTA, 0.5 ~tg/ml ethidium bromide (Berns et aL, 1980) . The BgllI fragments D and E of NIA-3 virus DNA were isolated from agarose gels by electrophoretic elution as described previously (Quint et aL, 1981) .
Filter hybridization. Transfer of DNA from agarose gels to nitrocellulose filters and hybridization were carried out essentially as described (Southern, 1975; Quint et al., 1981) . The DNA in the agarose gels was denatured by soaking the gel in 0.5 M-NaOH, 1-5 M-NaC1 for 45 min, then neutralized with 0.5 M-Tris-HCl pH 6.0, 1.5 M-NaC1 for an additional 45 min and transferred to BA-85 nitrocellulose filter paper (Schleicher & Schtill) overnight with 10 x SSC (1 x SSC is 0-15 M-NaC1, 5 mM-sodium citrate). After blotting, filters were rinsed in 2 x SSC, dried at room temperature, and baked under vacuum at 80 °C for 4 h.
Filters were preincubated for 4 h at 42 °C in 50% formamide, 5 x SSC, 0.25 mg/ml denatured salmon sperm DNA, 50 mM-sodium phosphate pH 7.0 and Denhardt's solution (Denhardt, 1966) . Hybridization was carried out in a solution containing 50% formamide, 5 x SSC, 1 mM-EDTA, 0.1 mg/ml denatured salmon sperm DNA, 20 mM-sodium phosphate pH 7.0, Denhardt's solution and 0.2 × l06 to 0-5 × 106 c.p.m./ml of purified NIA-3 virus DNA labelled with 32p by nick translation (Rigby et al., 1977; Berns et al., 1980) . The DNA probe was heatdenatured in 70% formamide at 100 °C for 10 min. Hybridization was performed at 42 °C for 16 h.
After hybridization, filters were washed three times at 42 °C in hybridization solution and twice in 0.1 × SSC containing 0.1% SDS at 42 °C. The filters were allowed to dry and exposed at -70 °C to X-ray film with Dupont Lightning-Plus intensifying screens.
To identify the origin of some of the bands generated by BamHl digestion, blots were hybridized with nicktranslated cloned BamHI fragments of PRV strain Ka, kindly provided by Dr T. Ben-Porat (Vanderbilt University School of Medicine, Nashville, Tenn., U.S.A.).
RESULTS
Restriction endonuclease patterns of PRV DNA generated by BamHI, KpnI, HindlII and BgllI and the positions of the restriction sites in the genome have been published by Ben-Porat and coworkers . Samples of viral or infected cell DNA were digested, subjected to electrophoresis on a 0-6% agarose gel and the fragments were transferred to a nitrocellulose filter. This was hybridized with 32p-labelled NIA-3 DNA (see Methods), washed and then autoradiographed. The NIA-3 fragments are numbered in order of decreasing size as described by . (Gielkens & Berns, 1982) . Moreover, these profiles were indistinguishable from the ethidium bromide-stained electrophoretic profiles of D N A extracted from purified virions. Apparently, the sequence homology between the NIA-3 strain of PRV, which was used as probe, and other PRV strains suffices to recognize all major BamHI fragments.
Differentiation of field isolates and vaccine virus strains
The D N A of the virulent NIA-3 strain, the moderately virulent strain Van Doorn and five vaccine virus strains was analysed by BamHI restriction endonuclease cleavage (Fig. 2) . The pattern generated for NIA-3 D N A was very similar to that reported by both with regard to the number and the approximate size of the fragments. A different cleavage pattern was obtained for PRV strain Van Doorn. The differences involved the apparent gain of at least one restriction site in fragment 2 and obvious changes in the mobility of fragments 10, 12, 13 and possibly 8'. All vaccine virus strains showed fragment profiles distinctly different from each other and from the wild-type cleavage patterns. Compared to the NIA-3 prototype pattern, the vaccine strain Ercegovac showed considerable changes involving absence of fragments 8, 8', 12, 13 and 14 and gain of a fragment migrating between bands 9 and 11. The digest of the iododeoxyuridine mutant MK-25 contained two additional fragment bands in the fragment 11 to 13 region. The most striking change in the Bartha vaccine profile was the absence of the 7 kbp fragment 7 and the occurrence of extra bands in the region between fragments 9 and 12.
A fragment band co-migrating with BamHI fragment 7 was also absent from digests of the DNA of the vaccine virus strains B-KAL and BUK. Both strains, however, contained two smaller sized fragments of 6.5 kbp and 6.0 kbp, respectively, which may have originated from fragment 7 by deletion. Further, the B-KAL restriction profile differed from that of NIA-3 by a larger size of presumably fragment 8', the presence of two extra fragments migrating between bands 9 and I l, and the absence of a cleavage product in the region expected for fragment 12.
Differentiation of Dutch field isolates
In Fig. 3 an example is shown of BamHI digests of the DNA of Dutch field isolates. The isolates shown were plaque-purified before analysis. The restriction pattern of isolate N-1 appeared to be identical to a plaque isolate from a pig vaccinated with Ercegovac, and that of N-3 to the pattern of a plaque isolate of MK-25 (compare with Fig. 6 , lanes 4 and 6). These isolates had been recovered from diseased pigs vaccinated shortly before PR problems arose.
The fragment patterns of the other isolates were distinctly different from those of the attenuated vaccines used in The Netherlands (Fig. 2) . Comparison of the cleavage patterns of these field isolates demonstrated considerable variation from one isolate to another. An exception was the case of isolates N-2 and N-11, which could not be differentiated by BamHI and KpnI (not shown). Whether isolates N-2 and N-11, which were recovered from a pig and a calf, respectively, are epidemiologically related is, unfortunately, unkown. The differences among the various field isolates can be ascribed to variation in the size of certain restriction fragments and the presence of extra BamHI cleavage sites. They will be discussed in more detail below.
Variability among field isolates of PRV
To study genome variability we examined field isolates from a number of European countries. Generally, these viruses represented unrelated outbreaks of PR in different species. BamHI cleavage patterns of representative isolates are shown in Fig. 4 . The profiles show considerable variation among the various isolates. As previously reported for herpes simplex virus (Lonsdale et al., 1980) these differences could be classified into two types. The first type of variation involved loss or gain of restriction endonuclease cleavage sites resulting in the generation of new fragments. The second type involved mobility differences in certain restriction fragments, apparently resulting from additions or deletions.
Using as a basis for differentiation only those variations resulting from loss or acquisition of BamHI restriction cleavage sites, the 92 different isolates examined could be subdivided into six different groups.
The first group (29 of 92 isolates) exhibited a fragment profile similar to that of the prototype NIA-3 strain and comprised strains from The Netherlands, France, Hungary and Northern Ireland (Fig. 4, lanes 1 to 4, 7, 15 and 16 ). The bands below BamHI fragment 4 in the digests shown in lanes 4 and 7 appeared to hybridize with cloned BamHI fragment 5" (data not shown). The second group (six of 92) was characterized by probably one extra BamHI site in the 35 kbp fragment 1, resulting in the appearance of two fragments of approximately 21 kbp and 14-5 kbp (Fig. 4, lanes 5, 6 and 9 ). The variation in mobility of the latter fragment is clearly apparent. These results were confirmed by hybridization with cloned BamHI fragment 1 (data not shown). The absence of fragment 1 was only observed among Dutch isolates. The third type of fragment profile was marked by the absence of fragment 2 and the appearance of two fragments of 11.5 kbp and 7.8 kbp (Fig. 4, lanes 10 to 14) . Because of migration around the position of fragments 5 and 6 the latter fragment was only detected by probing with cloned BamHI fragment 2 (data not shown). This type of profile was frequently (51 of 92) seen among Dutch and French isolates. The fourth group is represented by an Hungarian isolate showing an additional BamHI site in fragment 3, generating two fragments of about 17 and 2.6 kbp (Fig. 4, lane 17) . A rather exceptional cleavage profile was also obtained for one of the earliest Dutch isolates (fifth type). In this case additional BamHI cleavage sites were observed both in fragments 1 and 2 (Fig. 4 , lane 8). The only isolates for which loss of a BamHI restriction cleavage site was observed originated from Denmark (sixth type). These isolates from cattle (D-1 and D-2) and pigs (D-3 and D-4) were characterized by the absence of fragments 2 and 9 and the acquisition of a new fragment migrating slightly faster than fragment 1 (Fig. 4, lanes 18 to 21) . The second type of variability among the various field isolates of PRV concerned changes in the electrophoretic mobility of certain restriction fragments. The most striking differences involved at least one of the fragments migrating in the 5, 5' and 6 region of the gel and fragments 10, 12 and 13. Occasionally, we observed also some variation in size of one of the fragments migrating at the position of 8/8'.
According to the BamHI cleavage map of , fragments 5, 8, 8', 10, 12 and 13 are located in the inverted repeat (Rs) regions of the genome or span the junction between Rs and Us/UL. In order to verify this, we hybridized the BgllI fragments D/E of NIA-3 D N A , which are specific for the Rs and Us regions of the PRV genome, to blots containing BamHI fragments of field isolates (Fig. 5) . As expected, variability was observed in the mobility of IP: 54.70.40.11
On: Thu, 03 Jan 2019 13:26:47 fragments 5, 10, 12 and 13. The most striking difference involved the two-molar fragment 5, which maps within the invertible repeat segments TRs and IRs. In this region of the genome the extent of size variability between various strains may be as much as about 2 kbp. Occasionally, a ladder-like pattern of submolar bands was seen in the BamHI fragment 5 region (Fig. 4 , lanes 9 and 18). These fragments all hybridized to the BglII D/E probe and are therefore presumably the result of discrete stepwise additions of approximately 300 to 400 bp (Fig. 5, lane 9) . Smaller changes in electrophoretic mobility were observed for fragments 10 and 12, which span the junctions between Us and the repeat segments. Based on current data these fragments show size differences of up to 600 bp. Although the results presented revealed only minor changes in the mobility of the terminal TRs fragment 13, size variability up to 400 bp was seen.
Differentiation of pseudorabies virus isolates
In the restriction pattern of some field isolates two bands were discernible around the position of the three-molar, 8/8' band : one band co-migrating with the 8/8' band of NIA-3 and a second band of slightly lower mobility (Fig. 4, lanes 15 and 20) . The latter band hybridized with the cloned IRs/UL junction fragment 8' (data not shown). In autoradiographs of NIA-3 DNAprobed blots, however, fragment 8' was discernible only when the actual length of fragment 13 (1-5 to 1.9 kbp), which is located in the corresponding region of TRs, exceeded about 1.75 kbp.
The latter observation suggests that size variations in BamHI fragment 8' are confined to the inverted repeat.
Finally, all of the wild-type isolates presently examined exhibited an identical-sized BamHI restriction fragment 7 in the Us and indistinguishable fragment sizes for BamHI fragments 4, 9, 11 and 14 in the UL region of the PRV genome. strains. Lanes 1 to 4, Ercegovac parent virus stock, plaque isolate, virus recovered from an Ercegovacvaccinated pig, and a plaque isolate of the pig-passaged virus, respectively; lanes 5 and 6, MK-25 parent virus stock and plaque isolate; lanes 7 and 8, Bartha parent virus stock and plaque isolate; lanes 9 to 11, B-KAL parent virus stock, plaque isolate and virus recovered from a B-KAL-vaccinated pig, respectively; lanes 12 and 13, BUK parent virus stock and plaque isolate. Viral DNA fragments were detected as described in the legend to Fig. 2 . NIA-3 fragment numbers are given at the right-hand side of the figure.
Cleavage patterns of parent and plaque-purified virus DNA of vaccine strains and field isolates
As mentioned above, the D N A cleavage patterns of some of the vaccine strains revealed submolar fragment bands which had no obvious counterparts in the digest of the prototype NIA-3 virus DNA. Such heterogeneity in the gel profiles may reflect the presence of defective genomes or genetic variants in the uncloned parent virus population. To verify this assumption, the vaccine virus stocks were plaque-purified and analysed for their restriction endonuclease pattern.
Compared to the parent virus stocks, each of the plaque-purified isolates, except MK-25,
showed an altered restriction endonuclease pattern (Fig. 6 ). Minor changes in the BamHI pattern were also observed after one passage through pigs of the vaccine strains Ercegovac, B-K A L (Fig. 6) and Bartha (Fig. 7a) . The Ercegovac virus stock and a plaque isolate differed by the absence of two D N A fragments at about 9.0 kbp and 7.2 kbp in the cleavage pattern of the latter (Fig. 6, lanes 1 and 2) . However, only the 7.2 kbp band was missing in the gel profile of virus recovered from a pig vaccinated with Ercegovac (Fig. 6, lane 3) . A clonal isolate of this pig variant showed no further alterations (Fig. 6, lane 4) . The cleavage pattern of a plaque isolate of the Bartha vaccine strain differed from the uncloned parent virus by the loss of several submolar bands, which were visible only in overexposed autoradiographs of the uncloned parental virus and the acquisition of an extra fragment at 3.6 kbp (Fig. 6, lanes 7 and 8) .
IP
Compared to uncloned B-KAL, the gel pattern of a plaque isolate was characterized by a significant increase in the intensity of a 8.2 kbp fragment and a clearly decreased intensity of the slightly larger 8.4 kbp band (Fig. 6, lanes 9 and 10) . An inversion of the intensities of these bands was observed in an uncloned isolate from a pig (Fig. 6, lane 11) . Further analysis revealed the absence of a minor band of 2.6 kbp in the digest of both the plaque isolate and the pig isolate of B-KAL.
Major differences, including loss and acquisition of fragment bands were observed after plaque-purification of the vaccine virus BUK (Fig. 6, lanes 12 and 13) . Thus, the heterogeneity in the restriction pattern of vaccine stains may be due to the presence of variants. This was further studied in the next experiment.
Variation in the restriction pattern of clonally related plaque isolates of Bartha vaccine
To determine whether fragment pattern variation could be observed among clonally related isolates, ten plaques were selected from PK2 cells infected with the Bartha vaccine preparation. Plaque isolates were plaque-purified twice more and a virus stock was prepared for each progeny plaque.
Their restriction profiles were compared with those of uncloned Bartha vaccine, the avirulent strain Bartha K-61 of PRV from which the vaccine strain is derived, and an isolate (no. 82) recovered from an oral swab of a pig given Bartha vaccine (Fig. 7a) . The BamHI cleavage patterns of uncloned Bartha vaccine and K-61 were indistinguishable, except for the presence of a faint band migrating closely under fragment 13 in K-61 and three extra bands of about 6.1, 3.4 and 2.8 kbp in the Bartha vaccine. Since the latter bands were clearly visible only in overexposed autoradiographs their gel position is indicated by arrows. Isolate no. 82 showed two extra bands in the 8/8' and 11 regions of the gel.
With the exception of fragment 13, all major fragments recognized in the Bartha vaccine stock preparation and K-61 were also detected in clonally related isolates. However, apart from these prototype bands the cleavage profiles of eight plaque-purified clones revealed one or more additional fragments. This set of extra bands could be subdivided into two groups. These were, first, restriction fragments similar in size to those seen in over-exposed autoradiographs of the vaccine virus DNA digest, namely 6-1,3.4 and 2-8 kbp, and secondly, fragment bands which were absent or not easily discernible in the restriction profile of the uncloned vaccine virus e.g. fragments at about 8.2 kbp and 3.2 kbp.
The variations observed among the clonally related isolates from the Bartha vaccine virus strain are difficult to explain in terms of the structural organization of their viral genomes. Some insight in the identity of these viral sequences was provided by hybridization of the 32p_labelled BglII fragments D/E of NIA-3 to blots containing BamHI digests of plaque isolates. The viral DNA sequences represented by this probe comprise the repeat and short unique sequence.
As expected the labelled BglII D/E fragments hybridized to the BamHI fragments 5, 8/8', 10, 12 and 13 (Fig. 7b) . No annealing was observed in the fragment 7 region. However, all lanes revealed a new fragment at the position of the 3-2 kbp fragment 11 which was not detected in BgtII D/E-probed blots of a BamHI digest of the prototype strain NIA-3 (Fig. 7, lane 2) . Similar results were obtained when BamHI 7 was used as probe (data not shown). A 7 kbp fragment was seen in the DNA of the virulent strain NIA-3 and a smaller fragment of 3-2 kbp, designated 7' in K-61, Bartha vaccine and its clonally related isolates. Using the BglII D/E probe, the plaque isolates 1, 3, 7, 8 and 9 were distinguished from the parent virus and the other clonal isolates by the presence of an extra fragment band of variable size in the region of the deleted fragment 7'. An additional difference compared to the parent virus was seen in the digests of clones 8 and 9 and involved the detection with BglII D/E of a 8.2 kbp fragment, migrating slightly slower than fragment 5.
Interestingly, the BglII D/E probe did not hybridize to the BamHI fragments migrating at 6-1 kbp (clone 6), 3.4 kbp (clones 5 and 7) or 2.8 kbp (clones 2, 3, 8 and 9), indicating that they were derived from the UL region of the genome.
To exclude the possibility that alterations in the restriction patterns of the clonally related isolates had been introduced during the three roundS of plaque picking, a plaque isolate and a progeny plaque picked at each of two further rounds of plaque purification were analysed. The analysis showed that no changes in the number or electrophoretic mobility of the standard and an extra fragment of approximately 3.4 kbp had occurred (data not shown).
Together, these initial analyses of the Bartha vaccine and its clonally related isolates clearly demonstrate the presence of genetic variants in the uncloned vaccine.
DISCUSSION
The results of this study show that analysis of viral DNA with restriction endonucleases provides a method to distinguish PRV field strains. Furthermore, the method allows an unambiguous identification of vaccine virus strains. The latter applies both to vaccine stock preparations and to virus isolated from vaccinated pigs. On two occasions a PR field isolate recovered from diseased pigs proved to be attenuated vaccine virus. We do not exclude, however, that the disease was caused by a virulent virus present in the herd before vaccination.
Comparison of the DNA of 92 PRV isolates from four different European countries indicated that almost every isolate has a distinct BamHI fragment pattern. The alterations in the fragment profiles that distinguished these field isolates could be classified into two types. The first involved the gain or loss of BamHI cleavage sites, resulting in the loss of one or two fragments and the generation of new ones. This type of variability allowed subdivision of PRV isolates into six BarnHI fingerprint patterns. It is clear that the value of this type of strain classification has to be proven by examining many isolates from different geographical areas with a number of restriction endonucleases. Nevertheless, among the collection of isolates described in this paper and by others, two fragment patterns appear to be prevalent. These are, first, the NIA-3 prototype pattern (group one) which has been frequently observed among isolates from Central Europe (Herrmann et al., 1984) , Northern Ireland (D. Todd, personal communication) and the U.S.A. , and second, a fragment profile characterized by gain of at least one BamHI cleavage site in the BamHI fragment 2, which is frequently observed among Dutch and French PR viruses (group three). The predominance of this fingerprint profile among the viruses recovered in The Netherlands after 1981 is striking. This observation is confirmed by recent findings of Herrmann et al. (1984) with regard to German PRV isolates. These authors found group three patterns at higher frequency among the isolates collected in 1982. Further, they analysed PRV isolates from Denmark and Sweden. As for our Danish isolates, they found that all isolates lacked a BamHI cleavage site, i.e. instead of the BamHI fragments 2 and 9 a fusion fragment was observed. These findings may be indicative of an epizootiological relationship.
The second type of changes observed in the BamHI profiles of different strains concerned addition and/or deletion of nucleotide sequences yielding smaller or larger fragments. Based on the BamHI cleavage map of , the variable fragments of PRV map internally within the repeat regions of the genome (BamHI 5 and 13) or span the repeat-unique joint regions (BamH! 10, 12 and 8'). The results obtained by hybridizing the BglII D/E probe to blots of BamHI-cleaved DNA of different PRV strains are interpreted as supporting these map locations of the variable fragments. Furthermore, these data are in agreement with recent observations of Ben-Porat et al. (1984) that the most variable regions of the PRV genome are located within the repeats. However, these authors also observed a domain of variation within the BamHI fragment 5' which maps near the right end of the UL segment of the PRV genome.
Recent data of Wathen & Pirtle (1984) indicate that the latter type of variability can arise rapidly during passage of PRV in pigs. This finding is in agreement with the general opinion that non-identity of herpesvirus isolates has to be based on presence or absence of known cleavage sites.
Further investigation of PRV is required to map more precisely the regions of size variability described and to identify the nature of the DNA sequences involved. It is likely that, as shown for herpes simplex virus type 1 size heterogeneity is caused by additions and deletions of distinct DNA sequences (Davison & Wilkie, 1981) .
PRV vaccines showed characteristic alterations in their cleavage patterns which have not been observed so far among wild-type viruses. These alterations comprised the absence of BamHI fragments present in wild-type patterns and the appearance of additional bands some of which were present in submolar amounts. Most likely the absence of certain fragments is due to deletion of nucleotide sequences. In the case of the Bartha vaccine strain we were indeed able to demonstrate a deletion of 3.8 kbp within the Us BamHI fragment 7. This finding appears to be consistent with recent work of Lomniczi et al. (1984) , showing a deletion of approximately 4-3 kbp within the Us region of the Bartha vaccine virus genome.
Another feature of the live virus vaccines, with the exception of MK-25, was the presence of genetic variants in the uncloned virus preparation. Virus heterogeneity was apparent from the presence of submolar bands and could be resolved by plaque purification. For example, eight of ten plaque isolates of the Bartha vaccine preparation showed, apart from the standard pattern, one or more additional fragments. A blot hybridization experiment with the 32p-labelled BglII fragments D/E of NIA-3 DNA, allowed the localization of an extra fragment of about 3-2 kbp within the region comprising TRs, Us, IRs and the junction fragment 8', and extra fragments of 6.1, 3.4 and 2.8 kbp within the UL region. Data from recent experiments using BamHI restriction fragments of PRV DNA cloned in pBR325 (Ladin et al., 1982) , kindly provided by Dr T. Ben-Porat, allowed us to identify the extra fragments. A recombinant plasmid containing the UL fragment 5' hybridized to the 7.8 kbp fragment 5' and the extra fragments of 6-1, 3.4 and 2-8 kbp. The extra fragments detected by the BglII D/E probe hybridized to the cloned IRs/UL junction fragment 8'. These data lend additional support to the view that the Bartha virus vaccine preparation contains several genetic variants. In contrast, Lomniczi et al. (1984) obtained no evidence for the presence of variants in the Bartha preparation used in their study. A possible reason for this apparent contradiction might be that, although both preparations are derivatives of the Bartha K/61 strain (Bartha, 1961) , their further passage history in vitro has been different.
Furthermore, these authors reported that the genome of the Norden PRV vaccine, which had been derived from the BUK strain (Skoda et al., 1964) , is a class 3 DNA molecule, in which both Us and UL invert, giving rise to four isomeric forms of the genome. This conclusion was based on data indicating the presence in inverted orientation of a small sequence from the terminus of UL at the site of the junction of IR s and UL.
Work is in progress to determine whether the generation of the genetic variants of the Bartha virus vaccine has been effected by a similar type of genome rearrangement.
